[1] Govindan R,
Page N,
Morgensztern D,
et al.
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance,
epidemiologic,
and end results database.
J Clin Oncol 2006; 24:4539–44.
[2] El Naqa I,
Ten Haken RK Can radiomics personalise immunotherapy?
Lancet Oncol.
2018 Sep;19(9):1138-1139.
[3] McLaughlin J,
Han G,
Schalper KA,
et al.
Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer.
JAMA Oncol 2016; 2: 46–54.
[4] M.
Strzelecki,
P.
Szczypinski,
A.
Materka,
A.
Klepaczko,
A software tool for automatic classification and segmentation of 2D/3D medical images,
Nuclear Instruments & Methods In Physics Research A,
702,
2013,
pp.
137-140
[5] P.
Szczypinski,
M.
Strzelecki,
A Materka,
A.
Klepaczko,
MaZda-A software package for image texture analysis,
Computer Methods and Programs in Biomedicine,
94(1),
2009,
pp 66-76
[6] P.
Szczypinski,
M.
Strzelecki,
A.
Materka,
MaZda - a Software for Texture Analysis,
Proc.
of ISITC 2007,
November 23-23,
2007,
Republic of Korea,
pp.
245-249
[7] Tang C,
Hobbs B,
Amer A,
Li X,
Behrens C,
Canales JR,
Cuentas EP ,Villalobos P,
Fried D,
Chang JY,
Hong DS,
Welsh JW,
Sepesi B,
Court L,
Wistuba II,
Koay EJ.
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.
Sci Rep.
2018 Jan 31;8(1):1922.
[8] Opening the black box of machine learning.
Lancet Respir Med.
2018 Nov;6(11):801.
[9] Matzner-Lober E,
Suehs CM,
Dohan A,
Molinari N.
Thoughts on entering correlated imaging variables into a multivariable model: Application to radiomics and texture analysis.
Diagn Interv Imaging.
2018 May;99(5):269-270.